Abstract
Marek’s disease (MD) is caused by an oncogenic alphaherpesvirus, a common lymphoproliferative inducing agent usually characterized by mononuclear cellular infiltrates, mostly T-cell lymphomas in various visceral organs and peripheral nerves. The genome is linear and made up of double-stranded DNA molecules of nearly 160–180 kb in size. This was first reported by Dr. József Marek in the year 1907. Various pathotypes exist, and pathotyping is generally done based on the pathology the particular isolate induces in vaccinated and unvaccinated chickens and on their ability to overcome the effects of vaccination. Several avian species including both domesticated and wild birds are susceptible to Marek’s disease, and genetic susceptibility/resistance to MD is well characterized in chickens. The disease is highly contagious, and the transmission occurs mainly by the airborne route. The host responds to MDV infection by mounting both innate and adaptive immune mechanisms. The incidence of Marek’s disease is variable depending upon the pathotype and host susceptibility. Nerve lesions and visceral lymphomas are the prime pathologic changes noticed in MD. In the field, diagnosis is primarily based on the clinical signs and postmortem lesions. Apart from the above methods, virus isolation, identification of various viral markers in tissues, genomic detection assays (PCR, qPCR, nested PCR), and antibody detection (ELISA) aid in diagnosis of MD. Some of the strains used for vaccination are HVT, SB-1, and CVI988. Vaccination against MDV using these strains offers good protection. Despite effective vaccination regime, MD continues to be a threat to the industry due to the evolution of newer pathotypes. Thus, genetic resistance and strict biosecurity measures will be very critical adjuncts to vaccination in controlling the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abdul-Careem M, Hunter B, Nagy É et al (2006) Development of a real-time PCR assay using SYBR green chemistry for monitoring Marek’s disease virus genome load in feather tips. J Virol Methods 133:34–40. https://doi.org/10.1016/j.jviromet.2005.10.018
Angamuthu R, Baskaran S, Gopal D et al (2011) Rapid detection of the Marek’s disease viral genome in chicken feathers by loop-mediated isothermal amplification. J Clin Microbiol 50:961–965. https://doi.org/10.1128/jcm.05408-11
Baigent S, Petherbridge L, Howes K et al (2005) Absolute quantitation of Marek’s disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123:53–64. https://doi.org/10.1016/j.jviromet.2004.08.019
Baigent S, Nair V, Le Galludec H (2016) Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek’s disease virus. J Virol Methods 233:23–36. https://doi.org/10.1016/j.jviromet.2016.03.002
Benton W, Cover M (1957) The increased incidence of visceral lymphomatosis in broiler and replacement birds. Avian Dis 1:320. https://doi.org/10.2307/1587746
Biggs PM (1966) Avian leucosis and Marek’s disease. XIIIth World’s Poultry Congress symposium papers, Kiev USSR, pp 91–118
Biggs PM, Payne LN (1967) Studies on Marek’s disease. Experimental transmission. J Natl Cancer 39:267–280
Boodhoo N, Gurung A, Sharif S et al (2016) Marek’s disease in chickens: a review with focus on immunology. Vet Res 47:119. https://doi.org/10.1186/s13567-016-0404-3
Burgess S, Basaran B, Davison T (2001) Resistance to Marek’s disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype. Vet Pathol 38:129–142. https://doi.org/10.1354/vp.38-2-129
Calnek BW (1986) Marek’s disease: a model for herpesvirus oncology. CRC Crit Rev Microbiol 12:293–320
Cheng Y, Lee L, Smith E, Witter R (1984) An enzyme-linked immunosorbent assay for the detection of antibodies to Marek’s disease virus. Avian Dis 28:900. https://doi.org/10.2307/1590266
Churchill A, Biggs P (1967) Agent of Marek’s disease in tissue culture. Nature 215:528–530. https://doi.org/10.1038/215528a0
Churchill A, Baxendale W, Chubb R (1969) the attenuation, with loss of oncogenicity, of the herpes-type virus of Marek’s disease (Strain hprs-16) on passage in cell culture. J Gen Virol 4:557–564. https://doi.org/10.1099/0022-1317-4-4-557
Davidson F, Nair V (2004) Marek’s disease-an evolving problem. Elsevier Academic Press, Oxford
Davidson I, Malkinson M, Strenger C, Becker Y (1986) An improved ELISA method, using a streptavidin-biotin complex, for detecting Marek’s disease virus antigens in feather-tips of infected chickens. J Virol Methods 14:237–241. https://doi.org/10.1016/0166-0934(86)90025-x
Delecluse HJ, Schuller S, Hammerschmidt W (1993) Latent Marek’s disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells. EMBO J 12:3277–3286
Djeraba A, Kut E, Rasschaert D, Quéré P (2002) Antiviral and antitumoral effects of recombinant chicken myelomonocytic growth factor in virally induced lymphoma. Int Immunopharmacol 2:1557–1566. https://doi.org/10.1016/s1567-5769(02)00115-7
Gimeno I, Witter R, Fadly A, Silva R (2005) Novel criteria for the diagnosis of Marek’s disease virus-induced lymphomas. Avian Pathol 34:332–340. https://doi.org/10.1080/03079450500179715
Haesendonck R, Garmyn A, Dorrestein G et al (2015) Marek’s disease virus associated ocular lymphoma in Roulroul partridges (Rollulusrouloul). Avian Pathol 44:347–351. https://doi.org/10.1080/03079457.2015.1056088
Handberg K, Nielsen O, J⊘rgensen P (2001) The use of serotype 1- and serotype 3-specific polymerase chain reaction for the detection of Marek’s disease virus in chickens. Avian Pathol 30:243–249. https://doi.org/10.1080/03079450120054659
Hirai K (2001) Marek’s disease. Springer, Berlin/Heidelberg/Berlin/Heidelberg
Hirai K, Sakaguchi M (2001) Polyvalent recombinant Marek’s disease virus vaccine against poultry disease. Curr Top Microbiol Immunol 255:261–287
Hlozanek I, Mach O, Jurajda V (1973) Cell-free preparations of Marek’s disease virus from poultry dust. Folia Biol (Praha) 19:118–123
Igarashi T, Takahashi M, Donovan J et al (1987) Restriction enzyme map of herpesvirus of Turkey DNA and its collinear relationship with Marek’s disease virus DNA. Virology 157:351–358. https://doi.org/10.1016/0042-6822(87)90277-7
Islam A, Harrison B, Cheetham BF et al (2004) Differential amplification and quantitation of Marek’s disease viruses using real-time polymerase chain reaction. J Virol Methods 119:103–113. https://doi.org/10.1016/s0166-0934(04)00084-9
Izumiya Y, Jang HK et al (2001) A complete genomic DNA sequence of Marek’s disease virus type 2, strain HPRS24. Curr Top Microbiol Immunol 255:191–221
Jungherr E, Doyle LP et al (1941) Tentative pathologic nomenclature for the disease and/or for the disease complex variously designated as fowl leukemia, fowl leucosis, etc. Am J Vet Res 2:116
Kaupp B (1921) Paralysis of the domestic fowl. Poult Sci 2:25–31
Kishi M, Bradley G et al (1991) Inverted repeat regions of Marek’s disease virus DNA possess a structure similar to that of a sequence of herpes simplex virus DNA and contain host cell telomere sequence. J Virol 65:2791–2797
Kumar M, Barathidasan R, Palanivelu M et al (2016) A novel recombinant Meq protein based dot-ELISA for rapid and confirmatory diagnosis of Marek’s disease induced lymphoma in poultry. J Virol Methods 236:271–280. https://doi.org/10.1016/j.jviromet.2016.08.007
Lee S, Ohashi K, Sugimoto C, Onuma M (2001) Heparin inhibits plaque formation by cell-free Marek’s disease viruses in vitro. J Vet Med Sci 63:427–432. https://doi.org/10.1292/jvms.63.427
Lee L, Witter R, Reddy S et al (2003) Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek’s disease virus. Avian Dis 47:549–558. https://doi.org/10.1637/6073
Lee L, Cui X, Cui Z et al (2005) Characterization of a very virulent Marek’s disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens. Virus Genes 31:73–80. https://doi.org/10.1007/s11262-005-2202-2
Li Y, Sun A, Su S et al (2011) Deletion of the meq gene significantly decreases immunosuppression in chickens caused by pathogenic Marek’s disease virus. Virol J 8:2. https://doi.org/10.1186/1743-422x-8-2
Lupiani B, Lee L, Cui X et al (2004) Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. P Natl Acad Sci 101:11815–11820. https://doi.org/10.1073/pnas.0404508101
Marek J (1907) Multiple neuritis (polyneuritis) in chickens. Ger Vet Wkly 15:417–421
Moriguchi R, Fujimoto Y, Izawa H (1982) Chronological observations of feather pulp lesions in chickens inoculated with Marek’s disease virus. Avian Dis 26:375. https://doi.org/10.2307/1590108
Morrow C, Fehler F (2004) Marek’s disease a worldwide problem. In: Davison F, Nair V (eds) Marek’s disease. An evolving problem. Elsevier Academic Press, London, pp 8–16
Murata S, Chang K, Lee S et al (2007a) Development of a nested polymerase chain reaction method to detect oncogenic Marek’s disease virus from feather tips. J Vet Diagn Invest 19:471–478. https://doi.org/10.1177/104063870701900503
Murata S, Chang K, Yamamoto Y et al (2007b) Detection of the virulent Marek’s disease virus genome from feather tips of wild geese in Japan and the Far East region of Russia. Arch Virol 152:1523–1526. https://doi.org/10.1007/s00705-007-0982-5
Nair V (2005) Evolution of Marek’s disease – A paradigm for incessant race between the pathogen and the host. Vet J 170:175–183. https://doi.org/10.1016/j.tvjl.2004.05.009
Nazerian K (1973) Studies on intracellular and membrane antigens induced by Marek’s disease virus. J Gen Virol 21:193–195. https://doi.org/10.1099/0022-1317-21-1-193
Nazerian K, Witter R, Lee L, Yanagida N (1996) Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek’s disease virus. Avian Dis 40:368. https://doi.org/10.2307/1592234
Office International des Epizooties (2017). Chapter 2.3.13. Marek’s disease. In: Manual of diagnostic tests and vaccines for terrestrial animals
Okazaki W, Purchase H, Burmester B (1970) Protection against Marek’s disease by vaccination with a Herpesvirus of Turkeys. Avian Dis 14:413. https://doi.org/10.2307/1588488
Pappenheimer A (1929) Studies on fowl paralysis (neurolymphomatosis gallinarum): i. Clinical features and pathology. J Exp Med 49:63–86. https://doi.org/10.1084/jem.49.1.63
Pappenheimer AM, Dunn LC, Cone V (1929) Studies on fowl paralysis (Neurolymphomatosis gallinarum): I. Clinical features and pathology. J Exp Med 49:63–86
Payne LN, Biggs PM (1967) Studies on Marek’s disease. II. Pathogenesis. J Natl Cancer 39:281–302
Purchase HG, Biggs PM (1967) Characterization of five isolates of Marek’s disease. Res Vet Sci 8:440–449
Ross L, Binns M, Tyers P et al (1993) Construction and properties of a turkey herpesvirus recombinant expressing the Marek’s disease virus homologue of glycoprotein B of herpes simplex virus. J Gen Virol 74:371–377. https://doi.org/10.1099/0022-1317-74-3-371
Schat K (2000) Specific and nonspecific immune responses to Marek’s disease virus. Dev Comp Immunol 24:201–221. https://doi.org/10.1016/s0145-305x(99)00073-7
Schat K (2004) Understanding Marek’s disease immunity: a continuing challenge. Int J Poult Sci 3:89–95. https://doi.org/10.3923/ijps.2004.89.95
Schat K (2005) Isolation of Marek’s disease virus: revisited. Avian Pathol 34:91–95. https://doi.org/10.1080/03079450500059289
Schat K, Calnek B (1978) Characterization of an apparently nononcogenic Marek’s disease virus. J Natl Cancer Inst 60:1075–1082. https://doi.org/10.1093/jnci/60.5.1075
Schat AK, Nair V (2008) Marek’s disease. In: Saif YM, Fadly AM, Glisson JR, McDougald LR, Nolan LK, Swayne DE (eds) Diseases of poultry, 12th edn. Iowa, Iowa State University Press/Blackwell Publishing, pp 452–512
Schermuly J, Greco A, Härtle S et al (2015) In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus. P Natl Acad Sci 112:7279–7284. https://doi.org/10.1073/pnas.1424420112
Scholten R, Hilgers L, Jeurissen S, Weststrate M (1990) Detection of Marek’s disease virus antigen in chickens by a novel immunoassay. J Virol Methods 27:221–226. https://doi.org/10.1016/0166-0934(90)90138-6
Silva R, Barnett J (1991) Restriction endonuclease analysis of Marek’s disease virus DNA: differentiation of viral strains and determination of passage history. Avian Dis 35:487. https://doi.org/10.2307/1591212
Silva R, Gimeno I (2006) Oncogenic Marek’s disease viruses lacking the 132 base pair repeats can still be attenuated by serial in vitro cell culture passages. Virus Genes 34:87–90. https://doi.org/10.1007/s11262-006-0022-7
Silva R, Reddy S, Lupiani B (2003) Expansion of a unique region in the Marek’s disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation. J Virol 78:733–740. https://doi.org/10.1128/jvi.78.2.733-740.2004
Singh S, Barathidasan R, Kumar A et al (2012) Recent trends in diagnosis and control of Marek’s Disease (MD) in poultry. Pak J Biol Sci 15:964–970. https://doi.org/10.3923/pjbs.2012.964.970
Smith TW, Albert DM et al (1974) Ocular manifestations of Marek’s disease. Invest Ophthalmol 13(8):586–592
Solomon J, Witter R, Nazerian K, Burmester B (1968) Studies on the etiology of Marek’s disease. I. propagation of the agent in cell culture. Exp Biol Med 127:173–177. https://doi.org/10.3181/00379727-127-32649
Spatz S, Silva R (2006) Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek’s disease virus 1. Virus Genes 35:41–53. https://doi.org/10.1007/s11262-006-0024-5
Sun G, Zhang Y, Lv H et al (2017) A Chinese variant Marek’s disease virus strain with divergence between virulence and vaccine resistance. Viruses 9:71. https://doi.org/10.3390/v9040071
Tischer B, Fehler F, Osterrieder K et al (2002) A DNA vaccine containing an infectious Marek’s disease virus genome can confer protection against tumorigenic Marek’s disease in chickens. J Gen Virol 83:2367–2376. https://doi.org/10.1099/0022-1317-83-10-2367
Van der Walle N, Winkler-Junius E (1924). De-neuritis epizoötiebijte Barneveld tilt in the 1921st
Wei X, Shi X, Zhao Y et al (2012) Development of a rapid and specific loop-mediated isothermal amplification detection method that targets Marek’s disease virus meq gene. J Virol Methods 183:196–200. https://doi.org/10.1016/j.jviromet.2012.04.014
Witter R (1982) Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek’s disease virus1. Avian Pathol 11:49–62. https://doi.org/10.1080/03079458208436081
Witter R (1991) Attenuated revertant Serotype 1 Marek’s disease viruses: safety and protective efficacy. Avian Dis 35:877. https://doi.org/10.2307/1591624
Witter R, Kreager K (2004) Serotype 1 mutagenesis: approaching the threshold of vaccine efficacy in Marek’s disease. Avian Dis 48:768–782. https://doi.org/10.1637/7203-050304r
Witter RL, Calnek BW et al (2005) Classification of Marek’s disease viruses according to pathotype -philosophy and methodology. Avian Pathol 34:75–90
Zelnik V (2004) Diagnosis of Marek’s disease. In: Davison F, Nair V (eds) Marek’s disease-an evolving problem. Elsevier Academic Press, London, pp 157–167
Zhang Z, Liu S, Ma C et al (2015) Absolute quantification of a very virulent Marek’s disease virus dynamic quantity and distributions in different tissues. Poult Sci 94:1150–1157. https://doi.org/10.3382/ps/pev063
Acknowledgments
All the authors of the manuscript thank and acknowledge their respective universities and institutes.
Conflict of Interest
There is no conflict of interest.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mariappan, A.K., Munuswamy, P., Reddy, M.R., Singh, S.D., Dhama, K. (2019). Marek’s Disease Virus. In: Malik, Y., Singh, R., Yadav, M. (eds) Recent Advances in Animal Virology. Springer, Singapore. https://doi.org/10.1007/978-981-13-9073-9_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-9073-9_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9072-2
Online ISBN: 978-981-13-9073-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)